Prof. Dr. med. Andrea Pfennig
Research focus
- Prevention, early detection and early intervention in psychiatric disorders
- Development of diagnostic instruments for risk assessment and early intervention strategies
- Epidemiology and illness course research
- Development of clinical guidelines (incl. data-based therapy recommender systems)
- Evaluation of state-of-the-art models of integrated, patient-centered psychiatric care
Table of contents
Curriculum Vitae
Pfennig, Andrea, MD, MSc Epidemiology, Adjunct Professor |
|
Official position |
Head of Early Detection and Intervention Centre for psychiatric disorders, Department of Psychiatry and Psychotherapy, Medical Faculty, Carl Gustav Carus University Hospital, Technische Universität Dresden Senior physician, Day Clinic for Young People at the Centre for Mental Health, Carl Gustav Carus University Hospital, Medical Faculty, Technische Universität Dresden |
Institution |
University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany |
Business address |
Fetscherstraße 74, 01307 Dresden |
Academic education and degrees
1990-1993 |
Vocational education, State-qualified Nurse, University of Magdeburg |
1993-2000 |
MD in Medicine, Medical School, University of Magdeburg |
2002 |
Doctoral thesis, Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University of Magdebur |
2006 |
MSc Epidemiology, TU Berlin and University of Bielefeld |
2008 |
Board exams and specialization in Psychiatry and Psychotherapy |
2009-2015 |
Assistant Professor for Psychiatric Epidemiology and Illness Course Research, Medical Faculty, Technische Universität Dresden |
2015-present |
Adjunct Professor, Medical Faculty, Technische Universität Dresden |
Professional career
2000-2001 |
Research Physician, Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Otto-von-Guericke University Magdeburg |
2001 |
Postdoctoral Researcher, Department of Behavioral Neurology, Beth Israel Deaconess Medical Center, Harvard University Boston, USA. |
2002-2003 |
Research Physician, Max-Planck Institute of Psychiatry, Munich |
2003-2006 |
Research Physician, Department of Psychiatry and Psychotherapy, Charité-University Medicine Berlin, Campus Mitte (CCM) |
2003-2007 |
Postdoctoral Researcher, Institute of Social Medicine, Epidemiology and Health Economics, Charité - University Medicine Berlin, Campus Mitte |
2007 |
Postdoctoral Researcher, Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden |
2008-present |
Head of Early Detection and Intervention Centre for psychiatric disorders, Department of Psychiatry and Psychotherapy, Medical Faculty, Carl Gustav Carus University Hospital, Technische Universität Dresden |
2019-present |
Senior physician, Day Clinic for Young People at the Centre for Mental Health, Carl Gustav Carus University Hospital, Medical Faculty, Technische Universität Dresden |
Honors, awards and positions
2002 |
Travel Stipend, Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) |
2005 |
GlaxoSmithKline Stipend for Research on Affective Disorders |
2009 |
The Mitchell Balter Award, Journal of Clinical Psychopharmacology |
Since 2009 |
Executive Committee, Dresdner Bündnis gegen Depression e.V. |
Since 2011 |
Executive Committee, Sächsische Wissenschaftliche Gesellschaft für Nervenheilkunde e.V. (SWGN) |
Since 2011 |
Head of Devision on Prevention of Mental Disorders, German Association for Psychiatry, Psychotherapy and Psychosomatics(DGPPN) |
Current journal editorial positions
Since 2012 |
Chief Editor, In Balance, official journal of the Deutsche Gesellschaft für Bipolare Störungen e.V. (DGBS e.V.) |
Since 2012 |
Editorial Board, International Journal of Bipolar Disorders |
10 most important peer-reviewed papers
(10 out of 254, SCOPUS h-index: 35)
Leopold K, Bauer M, Bechdolf A, Correll CU, Holtmann M … Pfennig A. Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study. Bipolar Disord. 2020 Feb 28. Online ahead of print.
Pfennig A, Ritter PS, Höfler M, Lieb R, Bauer M et al. Symptom characteristics of depressive episodes prior to the onset of mania or hypomania. Acta Psychiatr Scand. 2016;133(3):196-204.
Ritter PS, Höfler M, Wittchen HU, Lieb R, Bauer M … Pfennig A et al. Disturbed sleep as risk factor for the subsequent onset of bipolar disorder - data from a 10-year prospective-longitudinal study among adolescents and young adults. J Psychiatr Res. 2015;68:76-82.
Pfennig A, Alda M, Young T, MacQueen G, J Rybakowski et al. Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay. Int J Bipolar Disord. 2014;2:1.
Leopold K, Ratzer S, Correll CU, Rottmann-Wolf M, Pfeiffer S … Pfennig A. Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: baseline results in the first 180 help-seeking individuals assessed at the Dresden high-risk project. J Affect Disord. 2014;152-154:427-33.
Leopold K, Ritter P, Correll CU, Marx C, Özgürdal S … Pfennig A. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J Affect Disord. 2012;136(3):1000-1010.
Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T et al. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. Bipolar Disord. 2010;12(4):390-6.
Beesdo K, Höfler M, Leibenluft E, Lieb R, Bauer M, Pfennig A. Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life. Bipolar Disord. 2009;11(6):637-49.
Pfennig A, Kunzel HE, Kern N, Ising M, Majer M et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry. 2005;57(4):336-42.
Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M … Pfennig A et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36(12):1319-25.